Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2221343 Target Snapshot

Opioid receptors; mu and delta · PROTEIN FAMILY · Mus musculus

35Compounds
11Assays
2Approved Drugs
31.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P42866. Use UniProt P42866 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P42866 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Opioid receptors; mu and delta as ChEMBL target CHEMBL2221343, mapped to UniProt P42866. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Opioid receptors; mu and delta
PROTEIN FAMILY · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL2221343
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P42866
Mu-type opioid receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Opioid receptors; mu and delta is the right protein anchor across sources, using UniProt P42866 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMu-type opioid receptor
UniProt AccessionP42866
Component TypeProtein
Sequence Length398 aa

Mu-type opioid receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Opioid receptors; mu and delta, mapped to UniProt P42866. ChEMBL maps the protein component as Mu-type opioid receptor. Sequence length is 398 aa.

Mapped IDP42866
Review nameOpioid receptors; mu and delta
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

KI17.0
EC5014.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4795492 10.5 EC50 0.03162 Preclinical
CHEMBL2151734 9.54 EC50 0.287 Preclinical
CHEMBL19019 9.06 Ki 0.871 Approved
CHEMBL2151735 8.89 EC50 1.3 Preclinical
CHEMBL20226 8.75 EC50 1.778 Preclinical
CHEMBL2151245 8.6 Ki 2.512 Preclinical
CHEMBL38874 8.57 EC50 2.69 Preclinical
CHEMBL1237164 8.46 Ki 3.467 Preclinical
CHEMBL2151247 8.38 Ki 4.169 Preclinical
CHEMBL963 8.33 Ki 4.677 Approved
Distribution

pChEMBL Value Distribution

0
5.0
3
5.5
2
6.0
2
6.5
2
7.0
1
7.5
7
8.0
6
8.5
1
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

NALTREXONE
CHEMBL19019
Approved 1984
OXYMORPHONE
CHEMBL963
Approved 1959
Assay Landscape

Assay Landscape

11
Total Assays
11
Tested Compounds
2
Assay Types
Functional — 8 assays, 11 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 4 4 6.2
cell membrane format 2 3 9.3
assay format 1 4 8.1
organism-based format 1 0
Binding — 3 assays, 10 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 10 7.6
protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine